Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Effect of zileuton and celecoxib on urinary LTE4 and PGE-M levels in smokers.

Mohebati A, Milne GL, Zhou XK, Duffield-Lillico AJ, Boyle JO, Knutson A, Bosworth BP, Kingsley PJ, Marnett LJ, Brown PH, Akpa EG, Szabo E, Dannenberg AJ.

Cancer Prev Res (Phila). 2013 Jul;6(7):646-55. doi: 10.1158/1940-6207.CAPR-13-0083. Epub 2013 May 16.

2.

Elevated levels of urinary prostaglandin e metabolite indicate a poor prognosis in ever smoker head and neck squamous cell carcinoma patients.

Kekatpure VD, Boyle JO, Zhou XK, Duffield-Lillico AJ, Gross ND, Lee NY, Subbaramaiah K, Morrow JD, Milne G, Lippman SM, Dannenberg AJ.

Cancer Prev Res (Phila). 2009 Nov;2(11):957-65. doi: 10.1158/1940-6207.CAPR-09-0093. Epub 2009 Oct 20.

3.

Levels of prostaglandin E metabolite and leukotriene E(4) are increased in the urine of smokers: evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway.

Duffield-Lillico AJ, Boyle JO, Zhou XK, Ghosh A, Butala GS, Subbaramaiah K, Newman RA, Morrow JD, Milne GL, Dannenberg AJ.

Cancer Prev Res (Phila). 2009 Apr;2(4):322-9. doi: 10.1158/1940-6207.CAPR-09-0005. Epub 2009 Mar 31.

4.

The nutritional prevention of cancer: 400 mcg per day selenium treatment.

Reid ME, Duffield-Lillico AJ, Slate E, Natarajan N, Turnbull B, Jacobs E, Combs GF Jr, Alberts DS, Clark LC, Marshall JR.

Nutr Cancer. 2008;60(2):155-63. doi: 10.1080/01635580701684856.

PMID:
18444146
5.

Selenium supplementation and colorectal adenomas: an analysis of the nutritional prevention of cancer trial.

Reid ME, Duffield-Lillico AJ, Sunga A, Fakih M, Alberts DS, Marshall JR.

Int J Cancer. 2006 Apr 1;118(7):1777-81.

6.

Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers.

Gross ND, Boyle JO, Morrow JD, Williams MK, Moskowitz CS, Subbaramaiah K, Dannenberg AJ, Duffield-Lillico AJ.

Clin Cancer Res. 2005 Aug 15;11(16):6087-93.

7.

Chemotherapy induces the expression of cyclooxygenase-2 in non-small cell lung cancer.

Altorki NK, Port JL, Zhang F, Golijanin D, Thaler HT, Duffield-Lillico AJ, Subbaramaiah K, Dannenberg AJ.

Clin Cancer Res. 2005 Jun 1;11(11):4191-7.

8.

Reflections on the landmark studies of beta-carotene supplementation.

Duffield-Lillico AJ, Begg CB.

J Natl Cancer Inst. 2004 Dec 1;96(23):1729-31. No abstract available.

PMID:
15572749
9.

Can selenium prevent colorectal cancer? A signpost from epidemiology.

Duffield-Lillico AJ, Shureiqi I, Lippman SM.

J Natl Cancer Inst. 2004 Nov 17;96(22):1645-7. Review. No abstract available.

PMID:
15547171
10.

Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial.

Duffield-Lillico AJ, Slate EH, Reid ME, Turnbull BW, Wilkins PA, Combs GF Jr, Park HK, Gross EG, Graham GF, Stratton MS, Marshall JR, Clark LC; Nutritional Prevention of Cancer Study Group.

J Natl Cancer Inst. 2003 Oct 1;95(19):1477-81.

PMID:
14519754
11.

Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial.

Duffield-Lillico AJ, Dalkin BL, Reid ME, Turnbull BW, Slate EH, Jacobs ET, Marshall JR, Clark LC; Nutritional Prevention of Cancer Study Group.

BJU Int. 2003 May;91(7):608-12.

12.

Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial.

Reid ME, Duffield-Lillico AJ, Garland L, Turnbull BW, Clark LC, Marshall JR.

Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1285-91.

13.

Prostate cancer and selenium.

Nelson MA, Reid M, Duffield-Lillico AJ, Marshall JR.

Urol Clin North Am. 2002 Feb;29(1):67-70. Review.

PMID:
12109357
14.

Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial.

Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF Jr, Slate EH, Fischbach LA, Marshall JR, Clark LC.

Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):630-9.

Supplemental Content

Loading ...
Support Center